Adial Pharmaceuticals, Inc. (ADIL)
USD 1.11
(-1.77%)
USD 1.11
(-1.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.8 Million | -11.18 Million | -11.94 Million | -7.63 Million | -6.33 Million | -2.49 Million |
| Net Income | -5.12 Million | -12.73 Million | -19.42 Million | -10.89 Million | -8.59 Million | -11.63 Million |
| Depreciation & Amortization | 564.00 | 60.5 Thousand | 55.1 Thousand | 564.00 | 565.00 | 563.00 |
| Deferred income taxes | -1.9 Million | -502.00 | -94.07 Thousand | -1.55 Million | - | 3.48 Million |
| Stock-based compensation | 1.82 Million | 3.37 Million | 4.24 Million | 2.01 Million | 1.6 Million | 5.36 Million |
| Change in working capital | -634.79 Thousand | -1.36 Million | 1.46 Million | 1.24 Million | 208.16 Thousand | -849.31 Thousand |
| Other non-cash items | -2.87 Million | -522 Thousand | 1.8 Million | 1.55 Million | 441.76 Thousand | 1.12 Million |
| Investing Cash Flow | 1.5 Million | - | -34.01 Thousand | -350 Thousand | - | - |
| Investments in PPE | 6.8 Million | - | -64.6 Thousand | - | - | - |
| Acquisitions | 1.5 Million | - | 30.58 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.5 Million | - | - | -350 Thousand | - | - |
| Financing Cash Flow | 4.13 Million | 9.12 Million | 13.64 Million | 5.6 Million | 9.24 Million | 6.34 Million |
| Debt repayment | - | - | - | - | - | -760 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1661.00 | - | - | - | - | - |
| Common Stock Issuance | 4.13 Million | 9.12 Million | 11.75 Million | 5.6 Million | 8.19 Million | 6.26 Million |
| Other Financing Activities | 4.13 Million | 9.12 Million | 1.89 Million | 5.6 Million | 1.05 Million | 841.25 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -159.41 Thousand | 108.34 Thousand | -353.77 Thousand | 458.53 Thousand | 90.53 Thousand | -34.8 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -634.79 Thousand | -1.47 Million | 1.81 Million | 786.48 Thousand | 117.63 Thousand | -814.5 Thousand |
| Cash at beginning of period | 4 Million | 6.06 Million | 4.4 Million | 6.77 Million | 3.86 Million | 18.24 Thousand |
| Cash at end of period | 2.82 Million | 4 Million | 6.06 Million | 4.4 Million | 6.77 Million | 3.86 Million |
| Capital Expenditure | 6.8 Million | - | -64.6 Thousand | - | - | - |
| Effect of forex changes on cash | -1 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -1.17 Million | -2.06 Million | 1.66 Million | -2.37 Million | 2.9 Million | 3.85 Million |
| Free Cash Flow | - | -11.18 Million | -12.01 Million | -7.63 Million | -6.33 Million | -2.49 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.45 Million | -6.47 Million | -7 Million | -1.9 Million | -1.34 Million | -843.91 Thousand |
| Depreciation & Amortization | 141.00 | 141.00 | 564.00 | 141.00 | 141.00 | -15.55 Thousand |
| Deferred income taxes | - | - | -1.9 Million | 37.18 Thousand | -296.43 Thousand | -987.54 Thousand |
| Stock-based compensation | 202.37 Thousand | 225.99 Thousand | 1.82 Million | 355.66 Thousand | 268.37 Thousand | 737.58 Thousand |
| Change in working capital | -114.84 Thousand | -30.1 Thousand | -794.2 Thousand | 222.9 Thousand | -311.81 Thousand | -822.9 Thousand |
| Other non-cash items | 285.87 Thousand | 4.8 Million | 1.14 Million | 421.29 Thousand | 296.43 Thousand | 37.9 Thousand |
| Investing Cash Flow | - | - | 1.5 Million | 350 Thousand | 350 Thousand | 800 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 1.5 Million | 350 Thousand | 350 Thousand | 800 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 1.5 Million | 350 Thousand | 350 Thousand | - |
| Financing Cash Flow | 411.09 Thousand | 3.82 Million | 4.13 Million | 3.38 Million | 138.66 Thousand | 58.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -1661.00 | 1661.00 | -1661.00 | - |
| Common Stock Issuance | 411.09 Thousand | 3.82 Million | 4.13 Million | 3.38 Million | 140.33 Thousand | 58.00 |
| Other Financing Activities | - | 3.82 Million | 4.13 Million | 3.38 Million | 140.33 Thousand | 58.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 139.25 Thousand | 74.14 Thousand | -159.41 Thousand | 37.82 Thousand | -27.77 Thousand | -305.76 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -254.1 Thousand | -104.24 Thousand | -634.79 Thousand | 185.08 Thousand | -284.03 Thousand | -517.14 Thousand |
| Cash at beginning of period | 5.02 Million | 2.82 Million | 4 Million | 315.88 Thousand | 1.21 Million | 2.31 Million |
| Cash at end of period | 3.28 Million | 5.02 Million | 2.82 Million | 2.82 Million | 315.88 Thousand | 1.21 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -1 Million | -2.5 Million | - | - |
| Net cash flow / Change in cash | -1.73 Million | 2.19 Million | -1.17 Million | 2.51 Million | -902.32 Thousand | -1.09 Million |
| Free Cash Flow | -2.14 Million | -1.62 Million | -6.8 Million | -1.22 Million | -1.39 Million | -1.89 Million |
2186
2351
5884
COG
NSGCF
LTRE